Kymera Therapeutics KYMR
NASDAQ KYMR
$134.84 -1.80 (-1.32%)
At close: Nov 11, 2026 · 4:00 PM EST

Kymera Therapeutics (KYMR) Total Liabilities (2019 - 2026)

Updated

Kymera Therapeutics (KYMR) posted Total Liabilities of $152.74 million for Q3 2026, down 2.0% from $155.79 million a year earlier but up 12.2% from the prior quarter.

Analysis

Kymera Therapeutics (KYMR) Total Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, Kymera Therapeutics' Total Liabilities came in at $163.15 million, up 14.6% from FY2024.

  • Annual Total Liabilities shows a five-year compound annual growth rate of -4.3% (FY2020 to FY2025).
  • In prior years, Kymera Therapeutics' Total Liabilities was $142.42 million in FY2024 (-21.2%), $180.79 million in FY2023 (+60.0%), $112.98 million in FY2022 (-22.8%) and $146.27 million in FY2021 (-28.0%).
  • Quarterly Total Liabilities has run from a low of $112.98 million in Q4 2022 to a high of $180.79 million in Q4 2023 over five years.
  • On a year-over-year basis, Total Liabilities has declined in each of the last three quarters, with an average decline of 2.3% over the last eight quarters.
  • The strongest year-over-year quarter for Total Liabilities in the past five years was Q4 2023, with growth of 60.0%; the weakest was Q1 2022, with a decline of 29.0%.
  • According to Business Quant data, Total Liabilities for the three prior quarters was $136.19 million (Q2 2026), $129.38 million (Q1 2026) and $163.15 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 107.80 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 115.90 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 152.26 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 87.83 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 68.11 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 81.70 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 38.37 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 115.70 Bn
10 Kymera Therapeutics 11.66 Bn 8.50 Bn - 152.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 152.74 Mn
Jun 30, 2026 136.19 Mn
Mar 31, 2026 129.38 Mn
Dec 31, 2025 163.15 Mn
Sep 30, 2025 155.79 Mn
Jun 30, 2025 159.59 Mn
Mar 31, 2025 132.08 Mn
Dec 31, 2024 142.42 Mn
Sep 30, 2024 141.91 Mn
Jun 30, 2024 141.10 Mn
Mar 31, 2024 157.05 Mn
Dec 31, 2023 180.79 Mn
Sep 30, 2023 156.84 Mn
Jun 30, 2023 146.52 Mn
Mar 31, 2023 151.90 Mn
Dec 31, 2022 112.98 Mn
Sep 30, 2022 125.59 Mn
Jun 30, 2022 125.47 Mn
Mar 31, 2022 134.34 Mn
Dec 31, 2021 146.27 Mn
API Access

Kymera Therapeutics Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=KYMR&period=max&api_key=YOUR_API_KEY